1 / 2

Drug Device Combination Market

Drug Device Combination Market

diksha3847
Download Presentation

Drug Device Combination Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Market Research Future Drug Device Combination Market by Value, Revenue, Segments, Mega trends, Prominent Players and Outlook to 2023 Drug Device Combination Market - Highlights The Global Drug Device Combination Market is expected to grow at an approximate CAGR of 11.4% during forecast period, 2018–2023. Drug-device combination is the combination of drugs and various medical devices that can be chemically/physically assembled as separate or cross labeled products. Factors such as increasing global burden of the diseases like cardiovascular diseases, urology diseases followed by growing healthcare expenditure, rising awareness for the market products drives the market growth. However, high cost of the products and related side effects, and presence of low income countries within the developing regions restricts the market to grow during the forecast period. Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6946 Players Covered: Some of the key players in the global drug device combination are 3M, Abbott Laboratories, AlloSource, Biomet Orthopedics, Inc., Biometrix Medical, Biotronik, Boston Scientific Corporation, C.R. BARD, Inc., Cook Critical Care, Inc., Covidien Ltd, Smith & Nephew Plc, St. Jude Medical Inc, Stryker Corporation, Wright Medical Group, Inc., Zimmer Holding, Inc., and others. Drug Device Combination Market – Segments Based on product, the market is segmented into catheter, advanced wound care products, and others. The catheter segment is sub-segmented into antimicrobial catheter, urological catheters, cardiovascular catheters, oximetry catheters, thermodilution catheters, wound drainage catheter, and others. The advanced wound care products segment is sub-divided into antibiotic wound care, bone graft substitutes, antibiotic bone cements, drug eluting stents, photodynamic therapy. The bone graft substitutes segment is sub-segmented into ceramic based bone graft substitute, allograft-based bone graft substitutes, cell-based bone graft substitutes, and others. On the basis of application, the market is devised into coronary angioplasty, tachycardia management, non-cardiovascular treatments, peripheral arterial disease (pad), bone treatment, antimicrobial applications, wound care, ophthalmic treatment, and others. By end user, the market is divided into hospitals & clinics, ambulatory centres, and academic & research organization, and others. In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely- the Americas, Europe, Asia-Pacific and the Middle East & African region. Regional Wise Analysis: In 2017, the Americas dominated the global drug device combination market. Factors such as rising prevalence of cardiovascular diseases, suitable reimbursement policies, high

  2. Market Research Future healthcare expenditure, and presence of major market players within the region drives the market to grow. Following a similar course, Europe stood second in the global drug device combination in 2017. This can be attributed to the presence of a well-developed healthcare infrastructure, increasing awareness for the combination products and presence of developed economies within the region. Asia Pacific was projected to be the fastest growing region in 2017, owing to increasing penetration of the market players within the region, growing healthcare sector and increasing government support for foreign investments. The Middle East and African region held least share in the global drug device combination market. Presence of poor economies and low per capita income, especially within the African region makes the market to lack within the region. Browse Complete Report at https://www.marketresearchfuture.com/reports/drug-device-combination- market-6946 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com

More Related